The specialty chemicals group Synthomer is intensifying its strategic transformation, with a recent partnership highlighting its commitment to sustainable, high-value solutions. The company has entered a collaboration with Belgian firm Woosh to develop circular economy approaches aimed at reducing waste in the diaper industry. This initiative is framed not merely as an environmental project but as a core component of Synthomer’s long-term commercial strategy.
Financial and Operational Resilience
Amid softer demand in certain end markets, Synthomer has relied on cost-reduction programs to bolster operational performance. The company is strengthening its position as a provider of essential high-performance polymers for critical sectors, including healthcare and industrial coatings. This focus on becoming a solutions platform is reflected in its financial composition: 55% of group revenue is now generated by its specialty chemicals division.
Sustainability as a Driver of Product Development
A significant shift in R&D priorities is evident in the company’s latest figures. According to its 2024 annual report, a substantial 69% of all newly introduced products offered distinct sustainability advantages, marking a clear increase from the previous year. The partnership with Woosh exemplifies this shift, targeting the extension of material lifecycles and a reduction in associated CO2 emissions. This drive responds directly to growing customer demand for eco-friendly alternatives in key markets such as construction and adhesives.
Should investors sell immediately? Or is it worth buying Synthomer?
Operational environmental targets are also being met. Management successfully reduced Scope 1 and Scope 2 greenhouse gas emissions by 7% year-on-year.
The financial impact of this strategic repositioning will soon become clearer. Synthomer has scheduled the publication of its full-year 2025 results for late April 2026.
Ad
Synthomer Stock: Buy or Sell?! New Synthomer Analysis from October 4 delivers the answer:
The latest Synthomer figures speak for themselves: Urgent action needed for Synthomer investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 4.
Synthomer: Buy or sell? Read more here...
